![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale
LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale
Read moreTue, 01st Feb 2022 07:40
LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale
Read more* EU demands faster deliveries in first hearing of legal case* AstraZeneca says lower supplies not in breach of contract* EU, UK vie for doses, Astra has under-delivered to both* Next hearings on May 26, EU seeks verdict before end of June (recast...
Read moreBROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone
Read more(Sharecast News) - Oxford Biomedica reported a 37% improvement in total revenues in its preliminary results on Thursday, to £87.7m.
Read moreOxford BioMedica annual revenue leaps on AstraZeneca vaccine deal
Read moreUK earnings, trading statements calendar - next 7 days
Read moreOxford Biomedica signs viral vectors pact with Boehringer Ingelheim
Read more(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new three-year development and supply agreement with Boehringer Ingelheim, it announced on Tuesday, for the manufacture and supply of various types of viral vectors.
Read moreLONDON MARKET PRE-OPEN: Returns in store for BP shareholders
Read moreBy Francesco GuarascioBRUSSELS, March 21 (Reuters) - The European Union is rebuffing British government calls to ship AstraZeneca COVID-19 vaccines produced in a factory in the Netherlands, an EU official said on Sunday.Former EU member Britain ha...
Read moreSanofi to terminate haemophilia development pact with Oxford Biomedica
Read more(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact on revenue.
Read moreIN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team
Read more* Astra had committed to at least 80 mln shots in Q1* EU funded two UK plants under deal with Astra - sources* Astra says UK has priority for doses produced there (Adds detail, background)By Francesco Guarascio and Sabine SieboldBRUSSELS, Jan 29 (Re...
Read moreIN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened
Read more